Related Experiment Video

Updated: Sep 26, 2026

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer

Liliana Puiu1, Eftichia Petrakou, Anastasia Apostolidou

  • 1Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biology, NCSR "Demokritos", GR-15310 Athens, Greece.

Cancer Letters
|April 23, 2003
PubMed

Insights

Breast cancer cells resist apoptosis due to Fas signaling. This study found no structural Fas gene alterations or shifts in transmembrane/soluble Fas mRNA in patients, suggesting other resistance mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Signaling

Background:

  • Fas (APO-1/CD95) is a key transmembrane receptor in apoptosis.
  • Fas expression in breast cancer cells does not induce apoptosis, indicating resistance.
  • Fas gene mutations and soluble Fas isoforms are implicated in other cancers.

Purpose of the Study:

  • To investigate structural alterations in critical Fas gene exons (6 and 9) in breast cancer.
  • To analyze the mRNA expression ratio of transmembrane versus soluble Fas isoforms in breast cancer.
  • To determine if Fas gene mutations or altered isoform expression contribute to apoptosis resistance in breast cancer.

Main Methods:

  • Direct sequencing of Fas gene exons 6 and 9 in 90 breast cancer patients.
  • Quantitative analysis of transmembrane and soluble Fas mRNA isoforms in 31 breast cancer samples and 14 controls.

Main Results:

  • No structural alterations were detected in exons 6 and 9 of the Fas gene.
  • The ratio of transmembrane to soluble Fas mRNA was not decreased in breast cancer samples compared to controls.
  • These findings exclude specific Fas gene mutations and isoform shifts as primary causes of resistance.

Conclusions:

  • Apoptosis resistance in breast cancer is not explained by structural mutations in Fas exons 6 or 9.
  • A shift towards soluble Fas isoform expression does not appear to be the mechanism of resistance.
  • Other cellular mechanisms likely mediate Fas-mediated apoptosis inhibition in breast cancer.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...